1-4 of 4
Colin Correnti
Close
Sort by
Journal Articles

T Cell Engaging Bispecific Antibodies Produce Durable Response in Mesothelin-Positive Patient-Derived Xenograft Models of Pediatric AML

Anilkumar Gopalakrishnapillai, Colin Correnti, Kristina Pilat, Ida Lin, Albe Man Kid Chan, Ashok D. Bandaranayake, Christopher Mehlin, Anne Kisielewski, Darcy Hamill, Allison Kaeding, Soheil Meshinchi, James Olson, E. Anders Kolb, Sonali P. Barwe
Journal: Blood
Blood (2021) 138 (Supplement 1): 1280.
https://doi.org/10.1182/blood-2021-151907
Published: 2021
Journal Articles

Recombinant CD19 Glycomutant Accurately and Reproducibly Detects CD19-Directed CAR-T Cells By Flow Cytometry

Delaney R. Kirchmeier, Alyssa Sheih, Salvatore Fiorenza, Alexandre V. Hirayama, Cassie Chou, Erik Kimble, Jordan Gauthier, Alison Williams, Jason Price, Colin Correnti, Cameron J. Turtle
Journal: Blood
Blood (2021) 138 (Supplement 1): 1724.
https://doi.org/10.1182/blood-2021-148229
Published: 2021
Journal Articles

Therapeutic Targeting of Mesothelin in Acute Myeloid Leukemia with Chimeric Antigen Receptor T Cell Therapy

Quy Le, PhD, Sommer Castro, BS, Thao T. Tang, Anisha Loeb, BA, Amanda R. Leonti, MS, Laura Pardo, Michael R. Loken, PhD, Colin Correnti, PhD, Soheil Meshinchi, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11.
https://doi.org/10.1182/blood-2020-143140
Published: 2020
Journal Articles

Mesothelin Targeting Bites for Pediatric AML: In Vivo Efficacy and Specificity

Anilkumar Gopalakrishnapillai, PhD, Colin Correnti, PhD, Anne Kisielewski, BS, Allison Kaeding, MD, Soheil Meshinchi, MD PhD, E. Anders Kolb, MD, Sonali Barwe, PhD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3925.
https://doi.org/10.1182/blood-2019-130941
Published: 2019